Stanford developing single-dose nanoparticle vaccine for COVID-19
‘Virtual biopsies’ could replace tissue biopsies in future thanks to technique developed by Cambridge scientists
6 January 2021How many people need to get a COVID-19 vaccine in order to stop the coronavirus?
6 January 2021Stanford developing single-dose nanoparticle vaccine for COVID-19
Before the pandemic, the lab of Stanford University biochemist Peter S. Kim focused on developing vaccines for HIV, Ebola and pandemic influenza. But, within days of closing their campus lab space as part of COVID-19 precautions, they turned their attention to a vaccine for SARS-CoV-2, the virus that causes COVID-19. Although the coronavirus was outside the lab’s specific area of expertise, they and their collaborators have managed to construct and test a promising vaccine candidate.
